Ireland JL - Search Results

1

BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.

Menzies-Gow NJ, Banse HE, Duff A, Hart N, Ireland JL, Knowles EJ, McFarlane D, Rendle D. Menzies-Gow NJ, et al. Among authors: ireland jl. Equine Vet J. 2024 Mar;56(2):220-242. doi: 10.1111/evj.14009. Epub 2023 Oct 5. Equine Vet J. 2024. PMID: 37795557 Review.

2

A cross-sectional study of geriatric horses in the United Kingdom. Part 1: Demographics and management practices.

Ireland JL, Clegg PD, McGowan CM, McKane SA, Pinchbeck GL. Ireland JL, et al. Equine Vet J. 2011 Jan;43(1):30-6. doi: 10.1111/j.2042-3306.2010.00145.x. Epub 2010 Aug 23. Equine Vet J. 2011. PMID: 21143631

3

A cross-sectional study of geriatric horses in the United Kingdom. Part 2: Health care and disease.

Ireland JL, Clegg PD, McGowan CM, McKane SA, Pinchbeck GL. Ireland JL, et al. Equine Vet J. 2011 Jan;43(1):37-44. doi: 10.1111/j.2042-3306.2010.00142.x. Epub 2010 Aug 23. Equine Vet J. 2011. PMID: 21143632

4

Does oral prednisolone treatment increase the incidence of acute laminitis?

Jordan VJ, Ireland JL, Rendle DI. Jordan VJ, et al. Among authors: ireland jl. Equine Vet J. 2017 Jan;49(1):19-25. doi: 10.1111/evj.12565. Epub 2016 Feb 15. Equine Vet J. 2017. PMID: 26713748

5

A multicentre study of long-term follow-up and owner satisfaction following enucleation in horses.

Wright K, Ireland JL, Rendle DI. Wright K, et al. Among authors: ireland jl. Equine Vet J. 2018 Mar;50(2):186-191. doi: 10.1111/evj.12743. Epub 2017 Sep 13. Equine Vet J. 2018. PMID: 28815702

6

Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors.

Ireland JL, McGowan CM. Ireland JL, et al. Vet J. 2018 May;235:22-33. doi: 10.1016/j.tvjl.2018.03.002. Epub 2018 Mar 8. Vet J. 2018. PMID: 29704935 Free article. Review.

7

Prevalence of owner-reported ocular problems and veterinary ocular findings in a population of horses aged ≥15 years.

Malalana F, McGowan TW, Ireland JL, Pinchbeck GL, McGowan CM. Malalana F, et al. Among authors: ireland jl. Equine Vet J. 2019 Mar;51(2):212-217. doi: 10.1111/evj.13005. Epub 2018 Aug 25. Equine Vet J. 2019. PMID: 30080275

8

Pharmacokinetics and pharmacodynamics of pergolide mesylate after oral administration in horses with pituitary pars intermedia dysfunction.

Rendle DI, Doran G, Ireland J, Edwards S. Rendle DI, et al. Domest Anim Endocrinol. 2019 Jul;68:135-141. doi: 10.1016/j.domaniend.2019.01.008. Epub 2019 Feb 8. Domest Anim Endocrinol. 2019. PMID: 31082785

9

Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: A systematic review.

Tatum RC, McGowan CM, Ireland JL. Tatum RC, et al. Among authors: ireland jl. Vet J. 2020 Dec;266:105562. doi: 10.1016/j.tvjl.2020.105562. Epub 2020 Oct 8. Vet J. 2020. PMID: 33323174 Free article.

10

Evaluation of the sensitivity and specificity of basal plasma adrenocorticotrophic hormone concentration for diagnosing pituitary pars intermedia dysfunction in horses: A systematic review.

Tatum RC, McGowan CM, Ireland JL. Tatum RC, et al. Among authors: ireland jl. Vet J. 2021 Sep;275:105695. doi: 10.1016/j.tvjl.2021.105695. Epub 2021 May 21. Vet J. 2021. PMID: 34099343 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters